BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22387237)

  • 1. Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred.
    Yu Y; Sanderson SR; Reyes M; Sharma A; Dunbar N; Srivastava T; Jüppner H; Bergwitz C
    Bone; 2012 May; 50(5):1100-6. PubMed ID: 22387237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.
    Bergwitz C; Roslin NM; Tieder M; Loredo-Osti JC; Bastepe M; Abu-Zahra H; Frappier D; Burkett K; Carpenter TO; Anderson D; Garabedian M; Sermet I; Fujiwara TM; Morgan K; Tenenhouse HS; Juppner H
    Am J Hum Genet; 2006 Feb; 78(2):179-92. PubMed ID: 16358214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient.
    Chi Y; Zhao Z; He X; Sun Y; Jiang Y; Li M; Wang O; Xing X; Sun AY; Zhou X; Meng X; Xia W
    Bone; 2014 Feb; 59():114-21. PubMed ID: 24246249
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hasani-Ranjbar S; Ejtahed HS; Amoli MM; Bitarafan F; Qorbani M; Soltani A; Yarjoo B
    J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):343-349. PubMed ID: 29809158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/NaPi-IIc can be masked by vitamin D deficiency and can be associated with renal calcifications.
    Kremke B; Bergwitz C; Ahrens W; Schütt S; Schumacher M; Wagner V; Holterhus PM; Jüppner H; Hiort O
    Exp Clin Endocrinol Diabetes; 2009 Feb; 117(2):49-56. PubMed ID: 18523928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC34A3 intronic deletion in a new kindred with hereditary hypophosphatemic rickets with hypercalciuria.
    Hasani-Ranjbar S; Amoli MM; Ebrahim-Habibi A; Dehghan E; Soltani A; Amiri P; Larijani B
    J Clin Res Pediatr Endocrinol; 2012 Jun; 4(2):89-93. PubMed ID: 22672866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary hypophosphatemic rickets with hypercalciuria and nephrolithiasis-identification of a novel SLC34A3/NaPi-IIc mutation.
    Phulwani P; Bergwitz C; Jaureguiberry G; Rasoulpour M; Estrada E
    Am J Med Genet A; 2011 Mar; 155A(3):626-33. PubMed ID: 21344632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intronic deletions in the SLC34A3 gene: a cautionary tale for mutation analysis of hereditary hypophosphatemic rickets with hypercalciuria.
    Ichikawa S; Tuchman S; Padgett LR; Gray AK; Baluarte HJ; Econs MJ
    Bone; 2014 Feb; 59():53-6. PubMed ID: 24176905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset hereditary hypophosphatemic rickets with hypercalciuria (HHRH) due to mutation of SLC34A3/NPT2c.
    Dhir G; Li D; Hakonarson H; Levine MA
    Bone; 2017 Apr; 97():15-19. PubMed ID: 27939817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.
    Bergwitz C; Miyamoto KI
    Pflugers Arch; 2019 Jan; 471(1):149-163. PubMed ID: 30109410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: presentation as hypercalciuria and nephrolithiasis.
    Tencza AL; Ichikawa S; Dang A; Kenagy D; McCarthy E; Econs MJ; Levine MA
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4433-8. PubMed ID: 19820004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary hypophosphatemic rickets with hypercalciuria: a study for the phosphate transporter gene type IIc and osteoblastic function.
    Yamamoto T; Michigami T; Aranami F; Segawa H; Yoh K; Nakajima S; Miyamoto K; Ozono K
    J Bone Miner Metab; 2007; 25(6):407-13. PubMed ID: 17968493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Spectrum of Hereditary Hypophosphatemic Rickets With Hypercalciuria (HHRH).
    Stürznickel J; Heider F; Delsmann A; Gödel M; Grünhagen J; Huber TB; Kornak U; Amling M; Oheim R
    J Bone Miner Res; 2022 Aug; 37(8):1580-1591. PubMed ID: 35689455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.
    Lorenz-Depiereux B; Benet-Pages A; Eckstein G; Tenenbaum-Rakover Y; Wagenstaller J; Tiosano D; Gershoni-Baruch R; Albers N; Lichtner P; Schnabel D; Hochberg Z; Strom TM
    Am J Hum Genet; 2006 Feb; 78(2):193-201. PubMed ID: 16358215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between compound heterozygous mutations of SLC34A3 and hypercalciuria.
    Abe Y; Nagasaki K; Watanabe T; Abe T; Fukami M
    Horm Res Paediatr; 2014; 82(1):65-71. PubMed ID: 24924704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis.
    Dasgupta D; Wee MJ; Reyes M; Li Y; Simm PJ; Sharma A; Schlingmann KP; Janner M; Biggin A; Lazier J; Gessner M; Chrysis D; Tuchman S; Baluarte HJ; Levine MA; Tiosano D; Insogna K; Hanley DA; Carpenter TO; Ichikawa S; Hoppe B; Konrad M; Sävendahl L; Munns CF; Lee H; Jüppner H; Bergwitz C
    J Am Soc Nephrol; 2014 Oct; 25(10):2366-75. PubMed ID: 24700880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).
    Zhu Z; Bo-Ran Ho B; Chen A; Amrhein J; Apetrei A; Carpenter TO; Lazaretti-Castro M; Colazo JM; McCrystal Dahir K; Geßner M; Gurevich E; Heier CA; Simmons JH; Hunley TE; Hoppe B; Jacobsen C; Kouri A; Ma N; Majumdar S; Molin A; Nokoff N; Ott SM; Peña HG; Santos F; Tebben P; Topor LS; Deng Y; Bergwitz C
    Kidney Int; 2024 May; 105(5):1058-1076. PubMed ID: 38364990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating pathogenicity of SLC34A3-Ser192Leu, a frequent European missense variant in disorders of renal phosphate wasting.
    Schönauer R; Petzold F; Lucinescu W; Seidel A; Müller L; Neuber S; Bergmann C; Sayer JA; Werner A; Halbritter J
    Urolithiasis; 2019 Dec; 47(6):511-519. PubMed ID: 30798342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digenic Heterozygous Mutations in SLC34A3 and SLC34A1 Cause Dominant Hypophosphatemic Rickets with Hypercalciuria.
    Gordon RJ; Li D; Doyle D; Zaritsky J; Levine MA
    J Clin Endocrinol Metab; 2020 Jul; 105(7):2392-400. PubMed ID: 32311027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Updates on rickets and osteomalacia: the role of NaPi-2c/SLC34A3 and hypophosphataemic rickets].
    Segawa H; Shiozaki Y; Minoshima S; Miyamoto K
    Clin Calcium; 2013 Oct; 23(10):1445-50. PubMed ID: 24076642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.